Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Jul 18, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19 KB Spectrum Pharmaceuticals Acquires Talon Therapeutics and Guides for Launch of Marqibo Later This Year ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data Jul 01, 2013 Tekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data 18.9 KB ... Read more Summary ToggleTekmira Announces Election of Directors May 17, 2013 Tekmira Announces Election of Directors 12.6 KB ... Read more Summary ToggleTekmira Presents LNP Technology Innovations at Scientific Symposium May 15, 2013 Tekmira Presents LNP Technology Innovations at Scientific Symposium 24.7 KB Highlights Include Advancements in LNP Potency, Lyophilization, and Subcutaneous Administration ... Read more Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2013 Results May 14, 2013 Tekmira Provides Corporate Update and Announces First Quarter 2013 Results 38.2 KB Conference Call at 4:00 pm Eastern Time Today ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results May 09, 2013 Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 12.3 KB ... Read more Summary ToggleTekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program May 08, 2013 Tekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program 22.8 KB Scope and Funding of Contract Expanded to Include New, More Potent LNP Formulation ... Read more Summary ToggleTekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR) Apr 10, 2013 Tekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR) 18.8 KB Researchers Examine LNP-Enabled WEE1-CSN5 siRNA Combination Therapeutic Against Liver Cancer ... Read more Summary ToggleTekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting Apr 09, 2013 Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting 26.2 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Year-End Audited 2012 Results Mar 27, 2013 Tekmira Provides Corporate Update and Announces Year-End Audited 2012 Results 38.2 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Pagination First page First Previous page Previous … Page 33 Current page 34 Page 35 Page 36 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Jul 18, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19 KB Spectrum Pharmaceuticals Acquires Talon Therapeutics and Guides for Launch of Marqibo Later This Year ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data Jul 01, 2013 Tekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data 18.9 KB ... Read more Summary ToggleTekmira Announces Election of Directors May 17, 2013 Tekmira Announces Election of Directors 12.6 KB ... Read more Summary ToggleTekmira Presents LNP Technology Innovations at Scientific Symposium May 15, 2013 Tekmira Presents LNP Technology Innovations at Scientific Symposium 24.7 KB Highlights Include Advancements in LNP Potency, Lyophilization, and Subcutaneous Administration ... Read more Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2013 Results May 14, 2013 Tekmira Provides Corporate Update and Announces First Quarter 2013 Results 38.2 KB Conference Call at 4:00 pm Eastern Time Today ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results May 09, 2013 Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 12.3 KB ... Read more Summary ToggleTekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program May 08, 2013 Tekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program 22.8 KB Scope and Funding of Contract Expanded to Include New, More Potent LNP Formulation ... Read more Summary ToggleTekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR) Apr 10, 2013 Tekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR) 18.8 KB Researchers Examine LNP-Enabled WEE1-CSN5 siRNA Combination Therapeutic Against Liver Cancer ... Read more Summary ToggleTekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting Apr 09, 2013 Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting 26.2 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Year-End Audited 2012 Results Mar 27, 2013 Tekmira Provides Corporate Update and Announces Year-End Audited 2012 Results 38.2 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Pagination First page First Previous page Previous … Page 33 Current page 34 Page 35 Page 36 … Next page Next Last page Last
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 12.3 KB
Tekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR) 18.8 KB
Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting 26.2 KB